OSAKA -- Hong Kong-based activist investor Oasis Management has built a 5.2% stake in troubled Japanese drugmaker Kobayashi Pharmaceutical, according to securities filings submitted Wednesday.
Oasis spent about 8.7 billion yen ($56 million) through Monday to acquire more than 4 million shares, according to a disclosure to the Kanto Local Finance Bureau, a regulator that includes Tokyo under its jurisdiction.
